ZOC-2019619

N/A

Report date: 2025/03/07 15:58:24
NME

Base Information

Drug NameZOC-2019619
Drug Alias NameZOC2019619ZOC-2019619
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhongshan Ophthalmic Center Sun Yat-Sen UniversityGuangzhou Runer Eye Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhongshan Ophthalmic Center Sun Yat-Sen UniversityGuangzhou Runer Eye Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A